Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Evolan Pharma AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 85,494 Less Arrow 66,220 Less Arrow 65,385
Financial expenses 763 Less Arrow 158 Less Arrow 132
Earnings before taxes 25,913 Less Arrow 21,017 Less Arrow 19,061
EBITDA 36,053 Less Arrow 27,554 Less Arrow 25,915
Total assets 91,697 Less Arrow 77,592 Less Arrow 54,003
Current assets 67,051 Less Arrow 44,226 Less Arrow 34,599
Current liabilities 20,513 Less Arrow 19,208 Less Arrow 14,967
Equity capital 65,877 Less Arrow 47,401 Less Arrow 35,762
- share capital 9 Equal arrow 9 More Arrow 10
Employees (average) 29 Less Arrow 27 Equal arrow 27

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 71.8% Less Arrow 61.1% More Arrow 66.2%
Turnover per employee 2,948 Less Arrow 2,453 Less Arrow 2,422
Profit as a percentage of turnover 30.3% More Arrow 31.7% Less Arrow 29.2%
Return on assets (ROA) 29.1% Less Arrow 27.3% More Arrow 35.5%
Current ratio 326.9% Less Arrow 230.2% More Arrow 231.2%
Return on equity (ROE) 39.3% More Arrow 44.3% More Arrow 53.3%
Change turnover 19,081 Less Arrow 6,132 More Arrow 12,249
Change turnover % 29% Less Arrow 10% More Arrow 23%
Chg. No. of employees 2 Less Arrow 0 Equal arrow 0
Chg. No. of employees % 7% Less Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.